Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

Loss of lifetime improved for patients with complications including stroke, HF and heart attack after a new atrial ...

Heart rhythm disorders occur when the electrical impulses that coordinate heartbeats function improperly, causing the heart ...

Sounds dramatic, but when it comes to certain dietary supplements, even a slight overdose can send your ticker into chaos. We ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Cadrenal Therapeutics will participate at this year's BIO International Convention 2025, taking place June 16-19, 2025 in Boston.

An Instagram post claims that Lauki can replace blood thinners. The claim is FALSE.ClaimIn an Instagram post, it is claimed ...

The Global Coagulation Monitoring Products Market is expected to reach at a CAGR of 5.6% during the forecast period 2025-2033. The Coagulation Monitoring Products Market is growing due to rising ...

Atrial fibrillation (AF) frequently complicates the management ... Data on the net clinical effect of warfarin in patients with ESRD are limited to observational studies. Many experiences have ...

A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons, finds that Medicare ...

Alcohol is one of the most commonly consumed substances in the world, exhibiting complex relationships with multiple aspects ...